(ATRO) Astronics - Ratings and Ratios
Lighting Systems, Power Systems, Test Equipment, Avionics Structures
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 56.1% |
| Value at Risk 5%th | 67.0% |
| Relative Tail Risk | -27.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.48 |
| Alpha | 194.27 |
| CAGR/Max DD | 2.36 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.442 |
| Beta | 0.987 |
| Beta Downside | 0.941 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.89% |
| Mean DD | 13.34% |
| Median DD | 12.80% |
Description: ATRO Astronics November 17, 2025
Astronics Corporation (NASDAQ:ATRO) designs and manufactures aerospace, defense, and electronics products through two operating segments: Aerospace, which supplies lighting, safety, power generation, seat-motion, structural, and avionics solutions to OEMs, airlines, and the U.S. Department of Defense; and Test Systems, which builds automated test equipment and training simulators for aerospace, defense, communications, and mass-transit customers.
In FY 2023 the company generated roughly $1.2 billion in revenue, with the Aerospace segment contributing about 65 % of sales and delivering an operating margin near 9 %. Backlog growth has been driven by a resurgence in commercial air travel and sustained U.S. defense spending, while the Test Systems segment benefits from increasing demand for high-mix, low-volume electronic testing as aircraft become more software-centric. A key sector catalyst is the global push toward greener, LED-based cabin lighting, which aligns with airlines’ fuel-efficiency and passenger-experience initiatives.
For a deeper quantitative assessment, you may find ValueRay’s analyst tools useful for modeling ATRO’s valuation under different demand scenarios.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (-3.09m TTM) > 0 and > 6% of Revenue (6% = 49.8m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 8.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 33.91% (prev 35.05%; Δ -1.14pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 74.3m > Net Income -3.09m (YES >=105%, WARN >=100%) |
| Net Debt (365.9m) to EBITDA (39.6m) ratio: 9.25 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.87 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (35.4m) change vs 12m ago 1.18% (target <= -2.0% for YES) |
| Gross Margin 27.48% (prev 23.75%; Δ 3.73pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 124.5% (prev 120.0%; Δ 4.51pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.32 (EBITDA TTM 39.6m / Interest Expense TTM 13.3m) >= 6 (WARN >= 3) |
Altman Z'' 4.00
| (A) 0.41 = (Total Current Assets 432.6m - Total Current Liabilities 151.0m) / Total Assets 682.2m |
| (B) 0.28 = Retained Earnings (Balance) 192.2m / Total Assets 682.2m |
| (C) 0.03 = EBIT TTM 17.6m / Avg Total Assets 666.9m |
| (D) 0.19 = Book Value of Equity 108.9m / Total Liabilities 573.3m |
| Total Rating: 4.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 50.84
| 1. Piotroski 5.0pt |
| 2. FCF Yield 2.22% |
| 3. FCF Margin 6.17% |
| 4. Debt/Equity 3.48 |
| 5. Debt/Ebitda 9.25 |
| 6. ROIC - WACC (= -4.52)% |
| 7. RoE -1.37% |
| 8. Rev. Trend 56.87% |
| 9. EPS Trend 75.17% |
What is the price of ATRO shares?
Over the past week, the price has changed by +8.12%, over one month by +10.96%, over three months by +49.47% and over the past year by +229.33%.
Is ATRO a buy, sell or hold?
- Strong Buy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ATRO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 62.8 | 15% |
| Analysts Target Price | 62.8 | 15% |
| ValueRay Target Price | 84.7 | 55.3% |
ATRO Fundamental Data Overview November 29, 2025
P/E Forward = 46.9484
P/S = 2.3434
P/B = 17.8754
P/EG = 1.4638
Beta = 1.134
Revenue TTM = 830.6m USD
EBIT TTM = 17.6m USD
EBITDA TTM = 39.6m USD
Long Term Debt = 334.0m USD (from longTermDebt, last quarter)
Short Term Debt = 6.02m USD (from shortTermDebt, last quarter)
Debt = 379.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 365.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.31b USD (1.95b + Debt 379.4m - CCE 13.5m)
Interest Coverage Ratio = 1.32 (Ebit TTM 17.6m / Interest Expense TTM 13.3m)
FCF Yield = 2.22% (FCF TTM 51.3m / Enterprise Value 2.31b)
FCF Margin = 6.17% (FCF TTM 51.3m / Revenue TTM 830.6m)
Net Margin = -0.37% (Net Income TTM -3.09m / Revenue TTM 830.6m)
Gross Margin = 27.48% ((Revenue TTM 830.6m - Cost of Revenue TTM 602.4m) / Revenue TTM)
Gross Margin QoQ = 30.51% (prev 25.81%)
Tobins Q-Ratio = 3.39 (Enterprise Value 2.31b / Total Assets 682.2m)
Interest Expense / Debt = 0.77% (Interest Expense 2.92m / Debt 379.4m)
Taxrate = 9.95% (-1.23m / -12.3m)
NOPAT = 15.8m (EBIT 17.6m * (1 - 9.95%))
Current Ratio = 2.87 (Total Current Assets 432.6m / Total Current Liabilities 151.0m)
Debt / Equity = 3.48 (Debt 379.4m / totalStockholderEquity, last quarter 108.9m)
Debt / EBITDA = 9.25 (Net Debt 365.9m / EBITDA 39.6m)
Debt / FCF = 7.13 (Net Debt 365.9m / FCF TTM 51.3m)
Total Stockholder Equity = 225.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.45% (Net Income -3.09m / Total Assets 682.2m)
RoE = -1.37% (Net Income TTM -3.09m / Total Stockholder Equity 225.8m)
RoCE = 3.14% (EBIT 17.6m / Capital Employed (Equity 225.8m + L.T.Debt 334.0m))
RoIC = 3.66% (NOPAT 15.8m / Invested Capital 431.4m)
WACC = 8.19% (E(1.95b)/V(2.33b) * Re(9.65%) + D(379.4m)/V(2.33b) * Rd(0.77%) * (1-Tc(0.10)))
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.78%
[DCF Debug] Terminal Value 63.55% ; FCFE base≈51.3m ; Y1≈33.7m ; Y5≈15.4m
Fair Price DCF = 7.49 (DCF Value 236.7m / Shares Outstanding 31.6m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 75.17 | EPS CAGR: 37.33% | SUE: 0.74 | # QB: 0
Revenue Correlation: 56.87 | Revenue CAGR: 17.35% | SUE: -0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.56 | Chg30d=+0.094 | Revisions Net=+2 | Analysts=4
EPS current Year (2025-12-31): EPS=1.82 | Chg30d=+0.134 | Revisions Net=+3 | Growth EPS=+67.0% | Growth Revenue=+7.1%
EPS next Year (2026-12-31): EPS=2.40 | Chg30d=+0.332 | Revisions Net=+3 | Growth EPS=+32.3% | Growth Revenue=+11.5%
Additional Sources for ATRO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle